Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (311-320 of 1,367) with videos related to

Pageof 137
Sort By:
Ejhaem|February 26, 2024
Does Caplacizumab for the management of thrombotic thrombocytopenic purpura increase the risk of relapse, exacerbation, and bleeding? An updated systematic review and meta-analysis based on revised criteria by the International Working Group for thrombotic thrombocytopenic purpuraNiraj Neupane, Sangharsha Thapa, Amir Mahmoud, et al.
Ejhaem|February 26, 2024
From primary myelofibrosis to chronic myeloid leukemia, <i>BCR::ABL1</i>+ B-Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolutionDevin Wang, Wataru Kamata, Fengxi Ye, et al.
Ejhaem|February 26, 2024
Transcranial Doppler ultrasound velocities in a population of unstudied African children with sickle cell anemiaNicole F O'Brien, Peter Moons, Hunter Johnson, et al.
Ejhaem|February 26, 2024
Cost and cost-effectiveness of immunotherapy in childhood ALL: A systematic reviewYolanda Scoleri-Longo, Petros Pechlivanoglou, Sumit Gupta
Ejhaem|February 26, 2024
Aleukemic congenital leukemia cutis preceding monocytic leukemia with favorable outcome: A case reportCaroline Lo Presti, Gautier Szymanski, Christine Lefebvre, et al.
Ejhaem|February 26, 2024
Patient and clinician beliefs about potential barriers to treatment of neuropathic pain for adolescents with sickle cell diseaseMatthew Rees, Holly Spraker-Perlman, Raechyl Moore, et al.
Ejhaem|February 26, 2024
Immune reconstitution inflammatory syndrome-associated lymphoma: A retrospective Brazilian cohortJuliano Cordova Vargas, Karin Zattar Cecyn, Mariana de Oliveira Marques, et al.
Ejhaem|February 26, 2024
Prevalence and clinical impact of CD56 and T-cell marker expression in acute myeloid leukaemia: A single-centre retrospective analysisInna Shaforostova, Simon Call, Georg Evers, et al.
Ejhaem|February 26, 2024
In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirinePaolo F Caimi, Mehdi Hamadani, Carmelo Carlo-Stella, et al.
Ejhaem|February 26, 2024
Uncovering an undisclosed diagnosis: a glucose-6-phosphate dehydrogenase deficiency diagnosis in a critically ill adultBrittany M Kasturiarachi, David Robinson, Kristine Karkoska, et al.
Pageof 137

Showing results (311-320 of 1,367) with videos related to

Sort By:
Pageof 137
Ejhaem|February 26, 2024
Does Caplacizumab for the management of thrombotic thrombocytopenic purpura increase the risk of relapse, exacerbation, and bleeding? An updated systematic review and meta-analysis based on revised criteria by the International Working Group for thrombotic thrombocytopenic purpuraNiraj Neupane, Sangharsha Thapa, Amir Mahmoud, et al.
Ejhaem|February 26, 2024
From primary myelofibrosis to chronic myeloid leukemia, <i>BCR::ABL1</i>+ B-Lymphoblastic leukemia, and back to primary myelofibrosis: An illustration of dynamic clonal evolutionDevin Wang, Wataru Kamata, Fengxi Ye, et al.
Ejhaem|February 26, 2024
Transcranial Doppler ultrasound velocities in a population of unstudied African children with sickle cell anemiaNicole F O'Brien, Peter Moons, Hunter Johnson, et al.
Ejhaem|February 26, 2024
Cost and cost-effectiveness of immunotherapy in childhood ALL: A systematic reviewYolanda Scoleri-Longo, Petros Pechlivanoglou, Sumit Gupta
Ejhaem|February 26, 2024
Aleukemic congenital leukemia cutis preceding monocytic leukemia with favorable outcome: A case reportCaroline Lo Presti, Gautier Szymanski, Christine Lefebvre, et al.
Ejhaem|February 26, 2024
Patient and clinician beliefs about potential barriers to treatment of neuropathic pain for adolescents with sickle cell diseaseMatthew Rees, Holly Spraker-Perlman, Raechyl Moore, et al.
Ejhaem|February 26, 2024
Immune reconstitution inflammatory syndrome-associated lymphoma: A retrospective Brazilian cohortJuliano Cordova Vargas, Karin Zattar Cecyn, Mariana de Oliveira Marques, et al.
Ejhaem|February 26, 2024
Prevalence and clinical impact of CD56 and T-cell marker expression in acute myeloid leukaemia: A single-centre retrospective analysisInna Shaforostova, Simon Call, Georg Evers, et al.
Ejhaem|February 26, 2024
In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirinePaolo F Caimi, Mehdi Hamadani, Carmelo Carlo-Stella, et al.
Ejhaem|February 26, 2024
Uncovering an undisclosed diagnosis: a glucose-6-phosphate dehydrogenase deficiency diagnosis in a critically ill adultBrittany M Kasturiarachi, David Robinson, Kristine Karkoska, et al.
Pageof 137